+ All Categories
Home > Health & Medicine > Thyroid Tumor

Thyroid Tumor

Date post: 07-May-2015
Category:
Upload: saeed-al-shomimi
View: 7,456 times
Download: 0 times
Share this document with a friend
53
THYROID TUMORS Salma Saud Al-Sharhan King Faisal University – Khobar Saudi Arabia
Transcript
Page 1: Thyroid Tumor

THYROID TUMORS

Salma Saud Al-SharhanKing Faisal University – Khobar

Saudi Arabia

Page 2: Thyroid Tumor

NORMAL ANATOMY OF THE THYROID GLAND:

Page 3: Thyroid Tumor

MICROSCOPIC PICTURE OF THE THYROID GLAND:

Page 4: Thyroid Tumor

TYPES OF THYROID CANCER:

Primary: Follicular epithelium – well differentiated papillary follicular Follicular epithelium – undifferentiated Anaplastic Parafollicular cells Medullary Lymphoid cells lymphoma Secondary : metastatic

Page 5: Thyroid Tumor

THE CAUSES:

Radiation exposure to thyroid gland in child hood Schneider AB etal,Radation-induced endocrine tumor Cancer treat res

1997;89:141

Family hx. : a 4 to 10 fold increased risk of well differentiated thyroid cancer in 1st degree relatives with this neoplasia

Galanti MR et al, risk of papillary and follicular thyroid carcinoma , Br J Cancer 1997;75:451

Page 6: Thyroid Tumor

THE CAUSES:

Iodine: Iodine-deficient diets may lead to increase the TSH level and considered goitrogenic

Thyroiditis: (Hashimoto's Disease) may develop into a form of cancer called lymphoma.

Page 7: Thyroid Tumor

TNM STAGING OF THYROID CANCER:

Page 8: Thyroid Tumor

EVALUATION OF THYROID TUMOR:

History:Age and GenderRapid increase in size, dyspnea,

dysphagia and hoarseness of voiceFamily Hx. Of thyroid cancerHx. Of irradiation On Examination:Firmness, Mobility, Size and adherence

to surrounding structuresPresence of lymphadenopathy

Page 9: Thyroid Tumor

INVESTIGATIONS:

FNAC: The accuracy cytological diagnosis

from FNA ranges from 70% to 97% and highly dependent on the skill of the physician and the cytopathologist interpreting it.

Burch HB. Endocrinol Metab Clin North Am 1995;24:663

Page 10: Thyroid Tumor

INVESTIGATIONS:

US: For the presence of malignant assosciations Microcalcification Irregular margins Hypervascularity Extra glandular extension

Frates MC et al, Doppler sonography aid in the predfcation of malignancy of predication of thyroid of nodules J US Med 2003;22:127

Page 11: Thyroid Tumor

INVESTIGATIONS:

US guided FNA : Decrease the nondiagnostic specimen Increase the sensitivity and specificity Avoiding vascular structures

Carmeci C et al, US guided FNA of thyroid masses 1998;8:283

Page 12: Thyroid Tumor

INVESTIGATIONS:Radionuclide Scan:To determine the functional status of the

nodule Hypofunctional “cold nodule”ule”Serum Calcitonin level:Routine measurement of calcitonin level

advocated by some authors to Dx. Medullary cancer is unknown

Page 13: Thyroid Tumor

Ten most common types of Cancer among Adult Saudis by Sex, 2001

Page 14: Thyroid Tumor

EASTERN REGION,2001

Page 15: Thyroid Tumor

PAPILLARY THYROID CANCER:

Cystic or Solid Most common (80-85%)Spread through lymphaticFemale: Male is 3:1

Page 16: Thyroid Tumor

PAPILLARY CANCER

Typical papillary projections and empty (orphan annie-eyed) nuclei

Page 17: Thyroid Tumor

CLINICAL PRESENTATION:Incidental as a small occult tumor <1cm (papillary

microcarcinoma)Mass in the Neck the commonest way papillary cancer presentsGlands in the Side of the NeckThe spread to local glands (sometimes called

erroneously "lateral aberrant thyroid"). Distant Spread Spread to lungs or bone is very rare but when it

occurs unlike most other cancers, cure is possible.

Page 18: Thyroid Tumor

THE FOLLICULAR CANCER:It is unifocal, thickly encapsulated

and shows invasion of both capsule and blood vessels

Spread by the blood stream and rarely

through lymphatic It is unusual tumor (5 -10%)

Page 19: Thyroid Tumor

CLINICAL PRESENTATION:

As a single lump in the thyroid: This is the common mode of presentation. As pain in a bone or a spontaneous

fracture: in case of metastases to bone through the

blood stream 

Page 20: Thyroid Tumor
Page 21: Thyroid Tumor

THE PROGNOSIS IN DIFFERENTIATEDTHYROID CARCINOMA:

The two dominant factors are the age at the diagnosis and the presence of distant metastases.

Mazzafferi El etal, Long term impact of initial surgical and medical therapy on thyroid cancer .Am J Med 1994;97:418

Recent several scoring systems based on multifactorial analysis of risk factors have been advise

Page 22: Thyroid Tumor
Page 23: Thyroid Tumor

Low risk High risk

Patient age < 45 y > 45 y

Tumor size < 4.0 cm

> 4.0 cm

Extrathyoidal extension

absent present

Distant metastases

absent present

High tumor grade

absent present

Page 24: Thyroid Tumor

THE TREATMENT OF WELL DIFFERENTIATED THYROID CANCER:

It Consists of a three- pronged attack :

Thyroid Surgery Radioactive iodine therapy Drug - Thyroxine therapy

Page 25: Thyroid Tumor

SURGERY: Acceptable surgical procedure to remove

thyroid tumor include Ipsilateral lobectomy Near total thyroidectomy Total thyroidectomy The recent American Thyroid Association

Guide lines recommended for more aggressive (total thyroidectomy ) for well differentiated thyroid carcinonoma

Cooper DS et al. Management guidelines for thyroid nodules ,Thyroid2006;19:109

Page 26: Thyroid Tumor
Page 27: Thyroid Tumor

SURGERY : With a 20-year follow up the incidence of

local recurrence with unilateral resection was (14%),whereas, for bilateral resection it was (2%) Brauckhoff M, et al surgery 2006;140:953

For gross involvement of trachea or esophagus resection of these structures with reconstruction

Cooper DS et al. Management guidelines for thyroid nodules , Thyroid2006;19:109

Page 28: Thyroid Tumor

RADIOIODINE THERAPY:

The Indications: 1.After Surgery to destroy any residual

thyroid cancer cells or residual normal thyroid tissue.

2.To treat thyroid cancer that has spread to the lymph nodes, lungs or bones.

3.To treat thyroid cancer recurrence after initial treatment by surgery or previous radioactive iodine or both.

Page 29: Thyroid Tumor

RADIOIODINE THERAPY: Recent American thyroid association

guide lines recommended radioiodine ablation for:

Pt. with stage III or IV disease All Pt. with stage II disease <45 yrs or > 45 yrs Selected Pt. with stage I disease those

with: large tumor ( >1.5 cm ) multifocality residual disease nodal metastasis

Cooper DS et al . Management guide line for patient with thyroid nodules and cancer . Thyroid 2006;16:109

Page 30: Thyroid Tumor

THYROXIN THERAPY :

Recent meta-analysis supported the efficacy of TSH suppression in preventing adverse clinical effect

High risk pt. are maintained at TSH level below 0.1 mU/ L

Low risk pt. TSH level at or below the normal range (0.1- 0.5 mU/ L)

McGriff NJ, et al. effect of thyroid hormone suppression therapy on thyroid cancer. Ann Med 2002;34:557

Page 31: Thyroid Tumor

THYROXIN THERAPY :

The degree of thyroid suppression is dictated by balancing the risk of recurrent thyroid cancer and subclinical thyrotoxicosis particularly the cardiovascular risks

Page 32: Thyroid Tumor

SURVEILLANCE:

Page 33: Thyroid Tumor

CLINICAL IMPACT OF MOLECULAR ANALYSIS ON THYROID MANAGEMENT:

PAILLARY CARCINOMA

FOLLICULAR CARCINOMA

CPTC PDPTC

MIFTC WIFTC PDFTC

Recurrence 10% 50% 10% 40% 60%Deathof disease

5% 40% 10% 40% 60%

RET/PTC 30% 10% 0% 0% 0%

BRAF 40% 70% 0% 0% 0%

P53 <5% <5% <5% <5% 40%

RAS <5% 40% 40% 50% 60%

Page 34: Thyroid Tumor

Looking at BRAF mutation detection of thyroid cancer in FNAB samples demonstrate a 100% specificity and sensitivity in cases of PTC carrying BRAF mutation.

Chung KW,etal. Detection of BRAF in FNA specimen of tyroid nodule.Clin Endocri

2006;65:660-6

Page 35: Thyroid Tumor

MEDULLARY THYROID CANCER:

These are tumors of parafollicular (C cells), which produce a hormone called calcitonin

Types of MTC : Sporadic MTC Familial MTC MEN 2A MEN 2B Familial Non- MEN

Page 36: Thyroid Tumor
Page 37: Thyroid Tumor

CLINCAL PRESENTATION:

Sporadic MTC: asymptomatic thyroid mass Familial MTC : screening stimulation test for

calcitonin or with molecular analysis ( detection of RET gene mutation)

Page 38: Thyroid Tumor

TREATMENT OF SPORADIC MTC:

C cells do not concentrate iodine so radioactive iodine is of no value in the management

Page 39: Thyroid Tumor

Surgery is the only definitive therapy of MTC:

Total thyroidectomy Central node dissection Ipsilateral modified radical neck dissection

Page 40: Thyroid Tumor

A TUMOR ERODING INTO THE CHEST WALL

Page 41: Thyroid Tumor

TREATMENT OF FAMILIAL MTC:

Based on the genetic test for the mutation of RET gene

Since different mutations in the RET gene are associated with variable disease aggressiveness

this leading to individualized treatment of pt. with inherited MTC

Page 42: Thyroid Tumor

MEN2A AND FMTC RX. :

Prophylactic thyroidectomy at age 5 to 6 years

Moley JF. Medullary thyroid carcinoma.

Curr Treat Options Onco 2003;4:339

Page 43: Thyroid Tumor

MEN2B RX.:

Thyroidectomy during infancy

Moley JF. Medullary thyroid carcinoma.

Curr Treat Options Onco 2003;4:339

Page 44: Thyroid Tumor

ANAPLASTIC CANCER OF THE THYROID:

It is a very aggressive tumor with a poor prognosis

A female to male ratio 1.5:1 and a mean age is 67 years

 It is commonest in areas of endemic goiter where there is chronic iodine deficiency.

ATC commonly related to prior diagnosis of well differentiated thyroid cancer

Mclver B et al, Anaplastic Thyroid Carcinoma surgery 2001;130;1028

Page 45: Thyroid Tumor

CLINICAL PRESENTATION:

a long-standing goiter that suddenly increases in size.

Local invasion lead to obstructive symptoms, hemoptysis, dysphagia and hoarseness

At the time of Dx. 25 to 50 % of Pt. have synchronous pulmonary metastases

Mclver B et al, Anaplastic Thyroid Carcinoma .Surgery 2001;130;1028

Page 46: Thyroid Tumor

A CT scan showing anaplastic cancer of the thyroid

A woman with anaplastic cancer of the thyroid

Page 47: Thyroid Tumor

SURGICAL TREATMENT OF ATC:

In the majority of cases surgery is limited to an open biopsy to exclude lymphoma

Mclver B et al, Anaplastic Thyroid Carcinoma .Surgery 2001;130;1028

Page 48: Thyroid Tumor

RADIOTHERAPY AND CHEMOTHERAP:

External beam radiotherapy (EBRR) as been used with limited success to treat locally recurrent ATC

Doxorubicin is the single most effective chemotherapeutic for ATC

Ain KB etal, treatment of anaplastic carcinoma of thyroid. (CATCHIT) Group. Tyroid 2000;10;587

Page 49: Thyroid Tumor

THYROID LYMPHOMA:

Thyroid lymphoma is relatively rare disease constituting <1% of all lymphoma and accounting for 2% of extranodal non- Hodgkin’s lymphoma

Female: Male ratio from 3:1 up to 8:1 Median age is seventh decade of life

Green LD et al, anaplastic thyroid cancer and 1ry thyroid lymphoma. J Surg Oncol 2006;94:725

Page 50: Thyroid Tumor

CLINICAL PRESENTATION:

Local invasion : hoarseness, dyspnea with stridor, or dysphagia

Hypothyroidism in case of Autoimmune thyroiditis or Hashimoto’s thyroiditis

Page 51: Thyroid Tumor

A 70 Y. old lady with diffuse large B cell lymphoma

Page 52: Thyroid Tumor

TREATMENT :

Primary treatment should be EBRT combined with Chemotherapy regimen based on histopathological subtype of lymphoma

Green LD et al, anaplastic thyroid cancer and 1ry thyroid lymphoma. J Surg Oncol 2006;94:725

Page 53: Thyroid Tumor

TREATMENT :

Primary treatment should be EBRT combined with Chemotherapy regimen based on histopathological subtype of lymphoma

Green LD et al, anaplastic thyroid cancer and 1ry thyroid lymphoma. J Surg Oncol 2006;94:725


Recommended